Last reviewed · How we verify

NCT06775717

Motor Imagery and Mirror Therapy on Synkinesis, Facial Asymmetry, Facial Function and QoF in Bell's Palsy Patients.

ENROLLING BY INVITATION NA Last updated 15 January 2025
What this trial tests

NA trial testing Motor Imagery with conventional Treatment in Bell Palsy in 42 participants. Enrolling by invitation.

Timeline
1 October 2024
Primary endpoint
1 February 2025
1 May 2025

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingsingle
Primary purposetreatment
Enrollment42
Start date1 October 2024
Primary completion1 February 2025
Estimated completion1 May 2025
Sites2 locations across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

18 and older, any sex, with Bell Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bell's palsy is a condition that causes sudden weakness in the muscles on one side of the face. The weakness makes half of the face appear to droop, difficulty in closing eyes and synkinesis. Mirror therapy and Motor imagery have shown promise in improving motor function and overall well-being. Participant will be assigned two groups, A and B. All the groups will receive interventions for five days a week for 8 weeks and treatment time will be 35 minutes. The outcome measuring scales used will be facial Clinometric Scale (FaCE), Synkinesis Assessment Scale and Sunnybrook facial grading system to assess facial symmetry, synkinesis and facial movements, data will be collected on SPSS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bell Palsy

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06775717.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing